TCM evidence-based capacity building and evidence-based implementation plan of TCM combined with chemotherapy in treatment of metastatic colorectal cancer:A bidirectional cohort study of Zhenqiliujun anti-cancer granules combined with mFOLFOX6/FOLFIRI regimen and bevacizumab/cetuximab in first-line treatment of advanced metastatic colorectal
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2705538
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: TCM combined with chemotherapy:MFOLFOX6 /FOLFIRI regimen + bevacizumab/cetuximab + Zhenqi Liujun cancer suppressant granules.;Chemotherapy group:MFOLFOX6 /FOLFIRI + bevacizumab/cetuximab
Primary outcome(s): Progression-free survival;Adverse incident
Study Design: Non randomized control
创建时间：
2021-04-15
